Corcept Therapeutics | CORT - 市值



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 11.95B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


市值 更改 日
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Alaunos Therapeutics USD 7M 2M 2026-03
ANI Pharmaceuticals USD 1.59B 293M 2026-08
Ardelyx USD 1.48B 63M 2026-03
Aurora Cannabis CAD 193.82M 133.39M 2026-03
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Canopy Growth CAD 557.13M 99.33M 2026-03
Corcept Therapeutics USD 9.33B 5.02B 2026-06
Eli Lilly USD 1.11T 18.32B 2026-08
J&J USD 611.36B 32.21B 2026-06
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Merck USD 324.18B 6.81B 2026-08
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Novartis USD 240.59B 67.17B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Pacira USD 1.28B 286M 2026-08
Pfizer USD 153.17B 14.73B 2026-08
Supernus Pharmaceuticals USD 2.58B 116M 2026-08
TG Therapeutics USD 7.63B 778M 2026-08